No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Winning Health Technology Group Co., Ltd. specializes in delivering comprehensive information technology solutions to hospitals and various medical service organizations throughout China. Their services cover the entire lifecycle of IT provision, from initial design, planning, and strategic consulting to development, system deployment, ongoing maintenance, and operational management. These advanced solutions are instrumental in establishing intelligent hospital environments, as well as powering regional, community, and public healthcare oversight platforms, medical insurance systems, and a broad spectrum of other health services. Founded in Shanghai, China, in 1994, the company was initially known as Shanghai Kingstar Winning Software Co., Ltd. before officially adopting its current name in January 2016.
www.winning.com.cnNo one on the platform currently holds 300253.SZ.
No tracked institution reports a position in 300253.SZ as of their last filing.
No one on the platform has traded 300253.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -24.3% | -1.5% | ||||
| Profit Margin % | -17.8% | 2.8% | 15.1% | |||
| Free Cash Flow Margin % | 15.9% | 2.3% | -0.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.5B | -2.2% | $0.02 | $0.01–$0.02 | — | 3 |
| 2027 | $2.8B | +15.3% | $0.10 | $0.07–$0.13 | — | 3 |
| 2028 | $3.3B | +15.6% | $0.18 | $0.11–$0.24 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300253.SZWinning Health Technology Group Co., Ltd. | $6.67 | +0.91% | $14.7B | — |
| 002432.SZAndon Health Co., Ltd. | $60.05 | +1.16% | $28.0B | — |
| 002901.SZDouble Medical Technology Inc. | $38.88 | -0.74% | $16.1B | — |
| 300204.SZStaidson (Beijing) BioPharmaceuticals Co., Ltd. | $19.46 | +0.00% | $8.8B | — |
| 300436.SZFujian Cosunter Pharmaceutical Co., Ltd. |
| $85.27 |
| +0.46% |
| $13.6B |
| — |
| 300573.SZShenyang Xingqi Pharmaceutical Co.,Ltd | $36.41 | +0.86% | $13.0B | — |
| 300676.SZBGI Genomics Co., Ltd. | $36.89 | +1.46% | $15.4B | — |
Source: Financial Modeling Prep · peers by sector/industry